Advertisement
Canada markets close in 5 hours 33 minutes
  • S&P/TSX

    21,962.43
    -49.29 (-0.22%)
     
  • S&P 500

    5,079.17
    +8.62 (+0.17%)
     
  • DOW

    38,474.76
    -28.93 (-0.08%)
     
  • CAD/USD

    0.7296
    -0.0025 (-0.34%)
     
  • CRUDE OIL

    82.89
    -0.47 (-0.56%)
     
  • Bitcoin CAD

    90,184.12
    -1,421.71 (-1.55%)
     
  • CMC Crypto 200

    1,427.79
    +3.69 (+0.26%)
     
  • GOLD FUTURES

    2,332.20
    -9.90 (-0.42%)
     
  • RUSSELL 2000

    2,005.11
    +2.47 (+0.12%)
     
  • 10-Yr Bond

    4.6620
    +0.0640 (+1.39%)
     
  • NASDAQ

    15,782.81
    +86.17 (+0.55%)
     
  • VOLATILITY

    15.70
    +0.01 (+0.06%)
     
  • FTSE

    8,054.97
    +10.16 (+0.13%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6816
    -0.0020 (-0.29%)
     

OWLT Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Owlet, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 17, 2022

NEW YORK, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) and certain of its officers, on behalf of shareholders who: (1) purchased or otherwise acquired Owlet between March 31, 2021, and October 4, 2021, inclusive (the “Class Period”); and/or (2) held Sandbridge common stock held as of June 1, 2021, and were eligible to vote at Sandbridge’s special meeting on July 14, 2021. Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/owlt.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) that Owlet was reasonably likely to be required to obtain marketing authorization for the Smart Sock because the FDA concluded it was a medical device; (2) that, as a result, Owlet was reasonably likely to cease commercial distribution of the Smart Sock in the U.S. until it obtained the requisite approval; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/owlt or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Owlet you have until January 17, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

ADVERTISEMENT

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com